Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Right to Try Act

A U.S. law that allows patients access to certain drugs that have not been approved by the U.S. Food and Drug Administration (FDA). The patient must be unable to receive the drug in a clinical trial and must have a life-threatening illness for which other treatments are not available. Drugs used under the Right to Try Act must have been tested in a phase 1 clinical trial (the first step of testing a new treatment in people) and must be undergoing study to be approved by the FDA. Companies who develop and make drugs determine whether to make their products available to patients who qualify for access under the Right to Try Act.
Search NCI's Dictionary of Cancer Terms